TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16272914

Group type: EXPERIMENTAL
Intervention: Half-strength peroxide cleansing and gauze wraps
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Half-strength peroxide cleansing and Xeroform wraps
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Saline cleansing and gauze wraps
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Saline cleansing and Xeroform wraps
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Antibacterial soap-and-water cleansing and gauze
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Antibacterial soap-and-water cleansing and Xeroform gauze
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Stable dressings with no pin cleansing
Number of subjects: 92
Study: 12050912

Group type: EXPERIMENTAL
Intervention: Interferon (IFN) therapy (3 MU three times a week for 12 months)
Number of subjects: 122

Group type: COMPARATOR
Intervention: No treatment (Control group)
Number of subjects: 122
Study: 11512193

Group type: EXPERIMENTAL
Intervention: Professional oral hygiene and patient education in oral hygiene
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 83
Study: 7529523

Group type: EXPERIMENTAL
Intervention: BEP (bleomycin, etoposide, cisplatin)
Number of subjects: 54

Group type: COMPARATOR
Intervention: EP (etoposide, cisplatin)
Number of subjects: 54
Study: 1981905

Group type: EXPERIMENTAL
Intervention: Lozenge containing 11 mg (-)-menthol
Number of subjects: 62

Group type: COMPARATOR
Intervention: Candy placebo lozenge
Number of subjects: 62
Study: 318493

Group type: EXPERIMENTAL
Intervention: Hydrallazine with cyclopenthiazide and oxprenolol
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Hydrallazine
Number of subjects: 37
Study: 31496465

Group type: EXPERIMENTAL
Intervention: Mid-upper arm circumference (MUAC)
Number of subjects: 1023

Group type: EXPERIMENTAL
Intervention: Height-for-age Z-score
Number of subjects: 1023

Group type: EXPERIMENTAL
Intervention: Weight-for-age Z-score
Number of subjects: 1023

Group type: EXPERIMENTAL
Intervention: Weight-for-height Z-score
Number of subjects: 1023
Study: 30694800

Group type: EXPERIMENTAL
Intervention: IVUS-guided DES implantation
Number of subjects: 336

Group type: COMPARATOR
Intervention: Control group (standard DES implantation)
Number of subjects: 336
Study: 27718079

Group type: EXPERIMENTAL
Intervention: Protocol 2 (fixed SSDE, 15 mGy)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Protocol 1 (fixed CTDIvol, 15 mGy)
Number of subjects: 52
Study: 24983847

Group type: EXPERIMENTAL
Intervention: 6RM bench press
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 6RM elastic band push-up
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 23384256

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium infusion for 2 weeks followed by oral magnesium capsules for 4 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo for 6 weeks
Number of subjects: 80
Study: 21841065

Group type: EXPERIMENTAL
Intervention: Sclerosing treatment with polidocanol
Number of subjects: 29
Study: 19214120

Group type: EXPERIMENTAL
Intervention: Nevirapine 400 mg once daily
Number of subjects: 289

Group type: COMPARATOR
Intervention: Nevirapine twice daily
Number of subjects: 289
Study: 15834456

Group type: EXPERIMENTAL
Intervention: i.v. pantoprazole
Number of subjects: 32

Group type: COMPARATOR
Intervention: i.v. ranitidine
Number of subjects: 32
Study: 12914883

Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 665

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 665

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 665
Study: 10579480

Group type: EXPERIMENTAL
Intervention: R116301 (300 mg, oral administration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8776639

Group type: EXPERIMENTAL
Intervention: Single ACT determination
Number of subjects: 100

Group type: COMPARATOR
Intervention: Average of two ACT values
Number of subjects: 100
Study: 1915428

Group type: EXPERIMENTAL
Intervention: Nicainoprol 400 mg
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Nicainoprol 600 mg
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Nicainoprol 200 mg
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 7146091

Group type: EXPERIMENTAL
Intervention: Lithium treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31409515

Group type: EXPERIMENTAL
Intervention: High-dose rosuvastatin (40 mg/day)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Low-dose rosuvastatin (10 mg/day)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no statin treatment)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (normocholesterolemic patients)
Number of subjects: 70
Study: 30661935

Group type: EXPERIMENTAL
Intervention: Experimental group (n=12) receiving weekly 15- to 30-minute telephone dietary counseling stressing 2.5 cups per week CVs and 3.5 cups per week GLVs.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Attention control group (n=12) receiving weekly 15- to 30-minute telephone dietary counseling focusing on general healthy eating for cancer survivors.
Number of subjects: 24
Study: 28225185

Group type: EXPERIMENTAL
Intervention: Miconazole nitrate-containing soap
Number of subjects: 75

Group type: COMPARATOR
Intervention: Miconazole-free placebo soap
Number of subjects: 75
Study: 25404659

Group type: EXPERIMENTAL
Intervention: Internet behavioral intervention (IBI; n = 77)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Education-only Internet-delivered eating and activity control group (IDEA; n = 77)
Number of subjects: 154
Study: 23359232

Group type: EXPERIMENTAL
Intervention: Medically indicated preterm birth (PTB)
Number of subjects: 765

Group type: EXPERIMENTAL
Intervention: Spontaneous preterm birth (SPTB)
Number of subjects: 765

Group type: EXPERIMENTAL
Intervention: Medically indicated PTB at < 30 weeks
Number of subjects: 765

Group type: COMPARATOR
Intervention: Medically indicated PTB vs SPTB
Number of subjects: 765
Study: 21546436

Group type: EXPERIMENTAL
Intervention: Sildenafil 80 mg tid
Number of subjects: 259
Study: 19049555

Group type: EXPERIMENTAL
Intervention: Peer-assisted clinical skills training (n = 66)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Postgraduates-assisted clinical skills training (n = 56)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Self-assessment of competence
Number of subjects: 122
Study: 16978286

Group type: COMPARATOR
Intervention: Standard laparoscopy (Group A)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Laparoscopic varicocelectomy with isosulphan blue (Group B)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 50
Study: 15554358

Group type: COMPARATOR
Intervention: Serine/Alanine (Ser/Ala) and Serine/Ser (Ser/Ser) genotypes in CFS patients
Number of subjects: 248

Group type: COMPARATOR
Intervention: Serine allele positive patients
Number of subjects: 248
Study: 11557911

Group type: EXPERIMENTAL
Intervention: Diacetylmorphine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Monoacetylmorphine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Diacetylmorphine and metabolites
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Morphine-d3
Number of subjects: 8
Study: 9226314

Group type: EXPERIMENTAL
Intervention: Once daily irradiation (2 Gy/day to 66-70 Gy) or twice daily irradiation (1.25 Gy B.I.D. to 70-75 Gy) +/− planned neck dissection (for ≥ N2A disease)
Number of subjects: 28
Study: 7965282

Group type: EXPERIMENTAL
Intervention: Nifedipine GITS 30 mg
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Nifedipine GITS 60 mg
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study: 3658552

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (MgSO4), 6 mg elemental Mg/kg body weight, over 1 h
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (MgSO4)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 29149349

Group type: EXPERIMENTAL
Intervention: Social exclusion (manipulated using the Cyberball game)
Number of subjects: 74
Study: 27676420

Group type: COMPARATOR
Intervention: Standard behavioral weight intervention (single weight counseling session)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Intense behavioral weight intervention (weight counseling at each study visit)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Olanzapine (2.5-20 mg/day)
Number of subjects: 203
Study: 25038733

Group type: EXPERIMENTAL
Intervention: DCEAS plus SSRI plus body electroacupuncture (n = 23)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Sham (non-invasive cranial electroacupuncture, n-CEA) plus SSRI plus body electroacupuncture (n = 20)
Number of subjects: 43
Study: 21918812

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 21

Group type: COMPARATOR
Intervention: Prudent diet
Number of subjects: 21
Study: 20688314

Group type: EXPERIMENTAL
Intervention: Bimatoprost plus timolol
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Travoprost plus timolol
Number of subjects: 89
Study: 18277180

Group type: EXPERIMENTAL
Intervention: Supervised aerobic exercise training (TRAINED; n=8)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Attention-time control (CONTROL; n=6)
Number of subjects: 14
Study: 15877227

Group type: EXPERIMENTAL
Intervention: (18)F-FDG PET
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: (99m)Tc-depreotide SPECT
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 28
Study: 14516219

Group type: EXPERIMENTAL
Intervention: Event-based prospective memory with varying intention complexity
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ongoing task performance
Number of subjects: 0
Study: 10880787

Group type: EXPERIMENTAL
Intervention: Bilateral stimulus and response conditions
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Visual P1 microstates
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Central P3 and pre-/post-response microstates
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Lateralized readiness potential
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (16 boys)
Number of subjects: 15
Study: 8650966

Group type: EXPERIMENTAL
Intervention: Evidence-based medicine approaches in medical education
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cochrane Collaboration methodologies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized controlled studies
Number of subjects: 0
Study: 1348916

Group type: EXPERIMENTAL
Intervention: nebivolol 5 mg once a day
Number of subjects: 23
Study: 2946740

Group type: EXPERIMENTAL
Intervention: Nifedipine, 10 mg four times daily for 6 months
Number of subjects: 241

Group type: COMPARATOR
Intervention: Placebo four times daily for 6 months
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Nifedipine (compliant patients)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Placebo (compliant patients)
Number of subjects: 241
Study: 30355395

Group type: EXPERIMENTAL
Intervention: Cooked eggplant and cooked rice (CE+R)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Cooked pak choi and cooked rice (CP+R)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Cooked cauliflower and cooked rice (CC+R)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Homogenised counterparts of CE+R, CP+R, and CC+R
Number of subjects: 16

Group type: COMPARATOR
Intervention: Pure rice
Number of subjects: 16
Study: 27207511

Group type: EXPERIMENTAL
Intervention: Metreleptin treatment
Number of subjects: 9
Study: 23398229

Group type: EXPERIMENTAL
Intervention: Brief interventions (BIs) for risk-drinking women
Number of subjects: 20
Study: 21552672

Group type: EXPERIMENTAL
Intervention: High-intensity exercise session
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low-intensity exercise session
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control session (no exercise)
Number of subjects: 10
Study: 19461297

Group type: EXPERIMENTAL
Intervention: AWS with bougie
Number of subjects: 30

Group type: COMPARATOR
Intervention: AWS only
Number of subjects: 30
Study: 17704494

Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal angioplasty (PTA) with selective stent placement
Number of subjects: 279

Group type: COMPARATOR
Intervention: Primary stent placement
Number of subjects: 279
Study: 14760126

Group type: EXPERIMENTAL
Intervention: Gemcitabine at 100 mg/m2 or 50 mg/m2 concurrent with radiotherapy (70 Gy over 7 weeks)
Number of subjects: 27
Study: 11704374

Group type: EXPERIMENTAL
Intervention: Inhaled carbon monoxide (CO) at 1,200 ppm to 1,500 ppm
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cigarette smoking (20 cigarettes per day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Inhaled air
Number of subjects: 12
Study: 9566060

Group type: EXPERIMENTAL
Intervention: Iridium-192
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 8065190

Group type: EXPERIMENTAL
Intervention: Histamine type 2 receptor antagonists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Omeprazole therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Promotility agents and surgical therapy
Number of subjects: 0
Study: 2903811

Group type: EXPERIMENTAL
Intervention: Terfenadine
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Loratadine
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 31356702

Group type: EXPERIMENTAL
Intervention: BCT+IBT
Number of subjects: 61

Group type: COMPARATOR
Intervention: IBT
Number of subjects: 61
Study: 28574026

Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise (heart rate reserve 40-60%) for 8 weeks
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 87
Study: 26142341

Group type: EXPERIMENTAL
Intervention: Danlou Tablet (4.5 g/day for 2 days before intervention, with a further 4.5 g/day for 90 days thereafter)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Danlou Tablet
Number of subjects: 220
Study: 23336123

Group type: EXPERIMENTAL
Intervention: Scheduled Telephone Intervention (STI)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 49
Study: 22105265

Group type: EXPERIMENTAL
Intervention: Nonoxynol-9 vaginal gel
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (hydroxyethyl cellulose placebo)
Number of subjects: 30
Study: 19965295

Group type: EXPERIMENTAL
Intervention: CT colonography (CTC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Expert panel recommendations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Centers for Medicare and Medicaid Services (CMS) decision
Number of subjects: 0
Study: 22852059

Group type: EXPERIMENTAL
Intervention: Regular consumption of fresh lean pork (up to 1 kg/week)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Control group (maintain habitual diet)
Number of subjects: 164
Study: 16005801

Group type: EXPERIMENTAL
Intervention: Chamfer preparation
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 135 degrees shoulder preparation
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 90 degrees shoulder preparation
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Gingival level preparations
Number of subjects: 90

Group type: COMPARATOR
Intervention: PVS impressions
Number of subjects: 90

Group type: COMPARATOR
Intervention: C-silicone impressions
Number of subjects: 90

Group type: COMPARATOR
Intervention: One-stage putty-wash technique
Number of subjects: 90

Group type: COMPARATOR
Intervention: Two-stage putty-wash technique
Number of subjects: 90
Study: 12211684

Group type: EXPERIMENTAL
Intervention: Universal ultrasound screening of all hips
Number of subjects: 15529

Group type: COMPARATOR
Intervention: Selective ultrasound screening (only for those at risk)
Number of subjects: 15529
Study: 9795412

Group type: EXPERIMENTAL
Intervention: Information form 1 (DIOmed)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Information form 2 (perimed compliance)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Information form 3 (PERIMED‐spitta)
Number of subjects: 218
Study: 8585970

Group type: EXPERIMENTAL
Intervention: Tetrandrine
Number of subjects: 321

Group type: COMPARATOR
Intervention: Calcium channel blockers (including nifedipine, verapamil, cinnarizine, tetrandrine)
Number of subjects: 321
Study: 2571822

Group type: EXPERIMENTAL
Intervention: Computer-aided diagnosis program (CAD‐A)
Number of subjects: 6962

Group type: EXPERIMENTAL
Intervention: Amended program (DIAG)
Number of subjects: 6962

Group type: COMPARATOR
Intervention: Clinical performance
Number of subjects: 6962
Study: 204954

Group type: EXPERIMENTAL
Intervention: Exogenously administered oestrogens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clofibrate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Depressed patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Perimenopausal female controls
Number of subjects: 0
Study: 29435729

Group type: EXPERIMENTAL
Intervention: Kuanxiong Aerosol (KA)
Number of subjects: 750

Group type: COMPARATOR
Intervention: Nitroglycerin (NT)
Number of subjects: 750
Study: 26710670

Group type: EXPERIMENTAL
Intervention: Brief motivational interviewing (MI)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: MI plus normative feedback (NF)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (MI only)
Number of subjects: 48
Study: 24065190

Group type: EXPERIMENTAL
Intervention: Merocel(®) packs
Number of subjects: 50

Group type: COMPARATOR
Intervention: Silicone splints
Number of subjects: 50
Study: 24089691

Group type: EXPERIMENTAL
Intervention: Oral naltrexone
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 22435613

Group type: EXPERIMENTAL
Intervention: Aloe whole leaf extract (AL with vitamins B(12), 1 mg and vitamin C 500 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Aloe fillet gel (AG with B(12) 1 mg and vitamin C 500 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Water (with vitamin B(12) 1 mg and vitamin C 500 mg)
Number of subjects: 15
Study: 19157139

Group type: EXPERIMENTAL
Intervention: Combination of traditional Chinese medicine (Changpikang) and ear acupoint therapy
Number of subjects: 262

Group type: COMPARATOR
Intervention: Traditional Chinese medicine group (Changpikang)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Ear acupoint group (spleen, large intestine, sympathesis, subcortex)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Treatment group (sulfasalazine)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Medicine and acupoint group (Changpikang and ear acupoint)
Number of subjects: 262
Study: 16176505

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (400 microg)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Rectal misoprostol (400 microg)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo (two lactose tablets rectally)
Number of subjects: 150
Study: 12925933

Group type: EXPERIMENTAL
Intervention: Donepezil (acetylcholinesterase inhibitor) for 12 weeks
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 10820860

Group type: EXPERIMENTAL
Intervention: Budesonide foam (1 mg/50 ml b.i.d.)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Mesalazine enemas (4 g/60 ml o.d.)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 33
Study: 8875971

Group type: EXPERIMENTAL
Intervention: Fluvastatin 20-40 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluvastatin 20 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose fluvastatin plus niacin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluvastatin 20 or 40 mg/day
Number of subjects: 0
Study: 1906028

Group type: EXPERIMENTAL
Intervention: 3 MU of recombinant interferon alfa‐2b
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 1 MU of recombinant interferon alfa‐2b
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 7039646

Group type: EXPERIMENTAL
Intervention: Fentanyl 80 micrograms
Number of subjects: 68

Group type: COMPARATOR
Intervention: Physiological saline (control)
Number of subjects: 68
Study: 31336654

Group type: EXPERIMENTAL
Intervention: CIT- PROT- (Citrulline with low protein intake)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: CIT- PROT+ (Citrulline with high protein intake)
Number of subjects: 73

Group type: COMPARATOR
Intervention: PLA-PROT- (Placebo with low protein intake)
Number of subjects: 73

Group type: COMPARATOR
Intervention: PLA-PROT+ (Placebo with high protein intake)
Number of subjects: 73
Study: 29290052

Group type: EXPERIMENTAL
Intervention: 125 mg of hydrocortisone
Number of subjects: 49

Group type: COMPARATOR
Intervention: Isotonic saline solution
Number of subjects: 49
Study: 27129045

Group type: EXPERIMENTAL
Intervention: rhBMP-2/ACS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Allograft
Number of subjects: 0
Study: 25406552

Group type: EXPERIMENTAL
Intervention: Behavioral therapy plus oral flunarizine
Number of subjects: 90

Group type: COMPARATOR
Intervention: Oral flunarizine alone
Number of subjects: 90
Study: 23098345

Group type: EXPERIMENTAL
Intervention: Prehospital aspirin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Aspirin in recommended initial dose (160-325 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Clopidogrel during hospitalization
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Diagnostic coronary angiography
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary interventions (PCI)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass graftings
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Mortality in high risk patients (GRACE score >140)
Number of subjects: 10
Study: 19751366

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 3
Study: 18845288

Group type: EXPERIMENTAL
Intervention: Sacrocolpopexy (SC)
Number of subjects: 322
Study: 16093252

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy plus 270 mg mebeverine taken thrice daily
Number of subjects: 149

Group type: COMPARATOR
Intervention: Mebeverine alone
Number of subjects: 149
Study: 12625151

Group type: EXPERIMENTAL
Intervention: Pyrantel-oxantel (10 mg/kg)
Number of subjects: 1329

Group type: COMPARATOR
Intervention: Mebendazole (500 mg)
Number of subjects: 1329